Ipamorelin vs HGH
10 sources
Start with ipamorelin, stacked with CJC-1295. It fires a pulse of your own GH without dragging cortisol, prolactin, or the heavy hunger of older peptides along, keeps your axis running, and is the gentle way to learn what more GH does for you. HGH is stronger, more reliable, and backed by real body-composition trials, and it is the step up when the stack tops out, or sooner if measurable fat loss is the goal. Ipamorelin alone against HGH is a mismatch; the stack against HGH is the real question.
How they differ
The difference that matters is how much GH, and whose. Ipamorelin is a growth-hormone secretagogue: it hits the ghrelin receptor and tells your pituitary to release a pulse of your own GH. That pulse is short and capped by what your pituitary can make, which is why nearly everyone pairs it with CJC-1295, a GHRH analog, a copy of the signal your hypothalamus sends, that primes the pituitary so the ipamorelin pulse lands bigger. HGH skips your pituitary: a set dose of the hormone every time, and your own production turns down in response. So the stack is the gentle route that keeps your axis working and has no outcome trials, and HGH is the reliable one with real trials and a real cost.
Ipamorelin’s own case is selectivity. It works the same ghrelin receptor as MK-677 without the wall of hunger that one brings, and it leaves cortisol and prolactin alone, so the stack costs you a head-rush after the shot and little else. HGH’s cost is the hormone’s: water, achy joints, tingling hands, and a blood sugar hit that grows with dose. One is a pre-bed pin on an empty stomach, the other a morning one.
If your search paired tesamorelin with ipamorelin, same logic. Tesamorelin is the approved GHRH analog, with real trials for visceral fat, and it slots in where CJC-1295 sits. It is still the axis route, not the hormone, and the call does not change.
What the research shows
Nobody has tested ipamorelin against HGH in people. The only same-study comparison is in mice:
A mouse is not you, but if it holds, the pulse does not cut fat and the hormone does. I still start you on the stack for gentleness and to keep your axis, not because it out-cuts HGH; if measurable fat loss is the goal, step to HGH sooner. HGH has the outcomes, with an asterisk on the water. Ipamorelin has a clean pulse and no outcome data at all.
How people run them
The stack is the start: ipamorelin at 200 to 300 mcg with 100 mcg of no-DAC CJC-1295 in one syringe, sub-q, pre-bed, two hours or more after your last meal. Reconstitute each vial separately before you draw them together. Add a morning or pre-training shot once the pre-bed one is routine. The receptor saturates low, so more ipamorelin mostly buys sides; timing and consistency buy GH. Give it a few months before you judge, and reassess every couple of months rather than running it on autopilot.
HGH, when you step up, is one morning pin on an empty stomach, 1 to 2 IU to start and 2 to 4 IU where most people land for body composition. Hold the dose that works.
Switch either way at the next slot, no washout, and don’t run ipamorelin on top of HGH: HGH turns your pituitary down, so the extra pins buy little.
Side effects, side by side
The same GH signals on both, at very different volumes; ipamorelin adds a head-rush and little else: